鼎泰高科
(301377)
| 流通市值：19.56亿 | | | 总市值：112.91亿 |
| 流通股本：7102.40万 | | | 总股本：4.10亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 423,285,501.23 | 1,579,629,986.34 | 1,128,573,047.08 | 712,571,217.92 |
| 营业收入 | 423,285,501.23 | 1,579,629,986.34 | 1,128,573,047.08 | 712,571,217.92 |
| 二、营业总成本 | 341,389,113.45 | 1,322,396,356.52 | 944,309,710.22 | 617,197,134.29 |
| 营业成本 | 262,239,300.75 | 1,014,194,207.99 | 727,009,142.68 | 465,617,732.49 |
| 税金及附加 | 3,477,025.49 | 12,808,603.29 | 8,913,362.55 | 5,486,654.3 |
| 销售费用 | 17,998,720.26 | 66,490,768.19 | 48,283,764.13 | 33,841,323.18 |
| 管理费用 | 28,956,002.77 | 110,876,494.05 | 73,962,667.28 | 52,018,784.38 |
| 研发费用 | 26,809,304.74 | 109,597,177.32 | 80,034,129.66 | 55,575,661.75 |
| 财务费用 | 1,908,759.44 | 8,429,105.68 | 6,106,643.92 | 4,656,978.19 |
| 其中:利息费用 | 1,746,052.7 | 8,794,079.79 | 6,877,379.1 | 4,933,973.27 |
| 其中:利息收入 | 516,034.18 | 2,057,045.83 | 1,472,897.89 | 1,045,993.12 |
| 加:公允价值变动收益 | 1,200,868.5 | 6,249,641.1 | 4,813,191.77 | 3,271,424.65 |
| 加:投资收益 | 1,874,463.2 | 6,987,452.57 | 5,228,950.75 | 3,025,225.18 |
| 资产处置收益 | -232,083.37 | -65,954.87 | 35,901.88 | 1,571.54 |
| 资产减值损失(新) | -7,118,124.53 | -17,292,686.2 | -11,833,619.35 | -7,965,029.63 |
| 信用减值损失(新) | -2,030,640.53 | -18,313,157.6 | -8,273,064.09 | -3,675,651.47 |
| 其他收益 | 5,874,832.12 | 28,571,685.4 | 21,172,563.58 | 10,082,357.11 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 81,465,703.17 | 263,370,610.22 | 195,407,261.4 | 100,113,981.01 |
| 加:营业外收入 | 13,078.55 | 135,335.3 | 82,194.7 | 9,546.98 |
| 减:营业外支出 | 46,815.93 | 5,726,577.95 | 404,931.48 | 352,933.97 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 81,431,965.79 | 257,779,367.57 | 195,084,524.62 | 99,770,594.02 |
| 减:所得税费用 | 9,307,915.8 | 30,473,195.99 | 22,523,527.01 | 10,745,985.79 |
| 六、净利润 | 72,124,049.99 | 227,306,171.58 | 172,560,997.61 | 89,024,608.23 |
| 持续经营净利润 | 72,124,049.99 | 227,306,171.58 | 172,560,997.61 | 89,024,608.23 |
| 归属于母公司股东的净利润 | 72,584,358.6 | 226,870,061.03 | 172,207,181.62 | 88,858,624.44 |
| 少数股东损益 | -460,308.61 | 436,110.55 | 353,815.99 | 165,983.79 |
| (一)基本每股收益 | 0.18 | 0.55 | 0.42 | 0.22 |
| (二)稀释每股收益 | 0.18 | 0.55 | 0.42 | 0.22 |
| 八、其他综合收益 | -182,920.29 | 2,069,679.03 | 3,031,909.07 | -2,503,663.17 |
| 归属于母公司股东的其他综合收益 | -182,920.29 | 2,069,679.03 | 3,031,909.07 | -2,503,663.17 |
| 九、综合收益总额 | 71,941,129.7 | 229,375,850.61 | 175,592,906.68 | 86,520,945.06 |
| 归属于母公司股东的综合收益总额 | 72,401,438.31 | 228,939,740.06 | 175,239,090.69 | 86,354,961.27 |
| 归属于少数股东的综合收益总额 | -460,308.61 | 436,110.55 | 353,815.99 | 165,983.79 |
| 公告日期 | 2025-04-23 | 2025-04-23 | 2024-10-24 | 2024-08-23 |
| 审计意见(境内) | | 标准无保留意见 | | |